Filter by: Subject

Filter by: Subject

Results Per Page:

Tuberculosis (TB) (238)
Mycobacterium tuberculosis (MTB) (47)
SDG-03: Good health and well-being (47)
Human immunodeficiency virus (HIV) (45)
South Africa (SA) (42)
Health sciences article SDG-03 (13)
Multidrug-resistant (MDR) (13)
Antimycobacterial (12)
Coronavirus disease 2019 (COVID-19) (9)
COVID-19 pandemic (9)
Veterinary science articles SDG-03 (9)
Drug resistance (8)
Infection (8)
Antiretroviral therapy (ART) (7)
Healthcare workers (HCWs) (7)
Mycobacterium tuberculosis (7)
Acquired immune deficiency syndrome (AIDS) (6)
Multidrug-resistant tuberculosis (MDR-TB) (6)
Positron emission tomography/computed tomography (PET/CT) (6)
Risk factors (6)
Treatment (6)
Bedaquiline (5)
Diagnosis (5)
Health sciences article SDG-17 (5)
Meerkat (Suricata suricatta) (5)
Patients (5)
SDG-17: Partnerships for the goals (5)
Transmission (5)
Children (4)
Extensively drug-resistant tuberculosis (XDR-TB) (4)
Minimum inhibitory concentration (MIC) (4)
Molecular docking (4)
Mortality (4)
Moxifloxacin (4)
Mycobacterium tuberculosis complex (MTBC) (4)
Occupational health (4)
Rubiaceae (4)
Screening (4)
Whole genome sequencing (WGS) (4)
Wildlife (4)
Antibiotics (3)
Bovine tuberculosis (bTB) (3)
Colony forming unit (CFU) (3)
Community health worker (CHW) (3)
Comorbidity (3)
Cytotoxicity (3)
Drug-resistant tuberculosis (DRTB) (3)
Ethiopia (3)
Hepatoprotective (3)
Metabolomics (3)
Molecular epidemiology (3)
Multi-drug resistant tuberculosis (MDR-TB) (3)
Mutation (3)
Mycobacterium bovis (3)
Mycolic acids (3)
Pulmonary tuberculosis (3)
Pyrazinamide (3)
SDG-01: No poverty (3)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (3)
Spoligotyping (3)
Tobacco (3)
Tuberculosis -- Treatment -- South Africa (3)
Tuberculosis transmission (3)
Whole-genome sequencing (WGS) (3)
Wildlife disease (3)
18F-FDG PET/CT (2)
68Ga-nitroimidazole PET/CT (2)
Abdominal lymphadenopathy (2)
Adherence (2)
Adults (2)
Africa (2)
African elephant (Loxodonta africana) (2)
Alcohol use (2)
Anthelmintic (2)
Anti-tuberculous treatment (ATT) (2)
Antibiotic resistance (2)
Antimicrobial resistance (AMR) (2)
Antiretroviral treatment (ART) (2)
Assay (2)
Bacteria (2)
Bactericidal activity (2)
Bedaquiline (BDQ) (2)
Care (2)
Catecholamines (2)
Ciprofloxacin (2)
Clofazimine (CFZ) (2)
Cluster randomized controlled trial (2)
Co-infection (2)
Colistin methanesulfonate (2)
Community-oriented primary care (COPC) (2)
Culture (2)
Drug discovery (2)
Drug screening (2)
Drug susceptibility testing (DST) (2)
Drug-resistant tuberculosis (2)
Drug-resistant tuberculosis (DR-TB) (2)
Efficacy (2)
Endoscopic ultrasound (2)
Enzyme-linked immunosorbent assay (ELISA) (2)
Epidemics (2)